StockClub

LXRX

LXRXLexicon Pharmaceuticals, Inc.$ --
Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc.

LXRX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
21M USD
YoY +1572.1%
Operating Income
-1M USD
YoY +96.1%
Net Income
-1M USD
YoY +95.9%
EPS
-0$
YoY +96.3%

Revenue

$21.1M
FY2024 Q2$2.8M
$2.8M
Q2
FY2024 Q3$4.5M
$4.5M
Q3
FY2024 Q4$31.1M
$31.1M
Q4
FY2025 Q1$1.3M
$1.3M
Q1
FY2025 Q2$30.1M
$30.1M
Q2
FY2025 Q3$44.3M
$44.3M
Q3
FY2025 Q4$49.8M
$49.8M
Q4
FY2026 Q1$21.1M
$21.1M
Q1
Actual
+$19.8M (+1572.1%)

Net Income

$-1M
FY2024 Q2$-101.8M
$-101.8M
Q2
FY2024 Q3$-166.6M
$-166.6M
Q3
FY2024 Q4$-200.4M
$-200.4M
Q4
FY2025 Q1$-25.3M
$-25.3M
Q1
FY2025 Q2$-22M
$-22M
Q2
FY2025 Q3$-34.8M
$-34.8M
Q3
FY2025 Q4$-50.3M
$-50.3M
Q4
FY2026 Q1$-1M
$-1M
Q1
Actual
+$24.3M (+95.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$24M
Est:$156.8M
FY2020MISS
$24M
FY2021BEAT
Actual:$298,000
Est:$194,667
FY2021BEAT
$298,000
FY2022BEAT
Actual:$139,000
Est:$137,000
FY2022BEAT
$139,000
FY2023MISS
Actual:$1.2M
Est:$3.6M
FY2023MISS
$1.2M
FY2024BEAT
Actual:$31.1M
Est:$11.1M
FY2024BEAT
$31.1M
FY2025BEAT
Actual:$49.8M
Est:$47.5M
FY2025BEAT
$49.8M

Analyst Estimates